Gyros Establishes Dedicated Office in Japan
News Sep 23, 2016
Gyros Protein Technologies AB has announced that it has established a dedicated office in Tokyo, Japan and has established Gyros Japan KK. The dedicated Japan team provides sales, applications and service support in Japan for the Company’s Gyros’ immunoassay business.
Gyros Japan KK replaces support previously provided under the distribution agreement in Japan with GE Healthcare for Gyros Protein Technologies’ nanoliter-scale immunoassay platform business (Gyrolab xP workstation, Gyrolab xPlore, related reagents, consumables and service).
GE Healthcare will continue providing support for sales, technical support and maintenance service until the end of December 2016. Gyros Japan KK will take over full responsibility for the region from January 2017, ensuring a smooth transition for customers.
Peter Luk, Vice President Asia-Pacific, Gyros Protein Technologies, said: “We are delighted to
announce the opening of the Japan office, and would like to thank GE Healthcare for their continued support during this transition period. This marks an important development for Gyros Protein Technologies and demonstrates the company’s commitment to the Asia-Pacific region, which has seen significant growth in the biotherapeutic discovery, development and manufacturing markets in recent years.”
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Vapourtec Collaboration with NPM Drives New Flow TechnologyNews
Flow chemistry engineering specialists Vapourtec (UK) have been engaged in a successful collaboration with New Path Molecular Research Ltd (NPM), focusing on the development of new reactor technology and methods for peptide synthesis.READ MORE